Glaucoma drug therapy in pregnancy: literature review and Teratology Information Service (TIS) case series

Marco De Santis, Marcella Pellegrino, Luisa D'Oria, Carmen De Luca, Giacomina Chiaradia, Angelo Licameli, Caterina Neri, Marta Nucci, Daniela Visconti, Alessandro Caruso

Risultato della ricerca: Contributo in rivistaArticolo in rivista

4 Citazioni (Scopus)

Abstract

BACKGROUND: there are many contradictions about pregnancy and fetal/neonatal outcomes after topical use of timolol alone or timolol in combination with other antiglaucoma medications. METHOD: Seventy-five pregnant women exposed to antiglaucoma medications were followed prospectively by phone interviews. 27 women used timolol as monotherapy, 48 women used timolol as part of multidrug therapy. We selected a control group of 187 healthy pregnant women. RESULTS: topical use of timolol alone or timolol in combination with other antiglaucoma medications don't influence pregnancy or fetal/neonatal outcomes. CONCLUSION: beta-blocker is the first choice treatment for glaucoma in pregnancy but, when necessary, multidrug therapy should not to be excluded.
Lingua originaleEnglish
pagine (da-a)N/A-N/A
RivistaCurrent Drug Safety
DOI
Stato di pubblicazionePubblicato - 2017

Keywords

  • pregnancy, glaucoma, congenital malformations, teratology, eye

Fingerprint

Entra nei temi di ricerca di 'Glaucoma drug therapy in pregnancy: literature review and Teratology Information Service (TIS) case series'. Insieme formano una fingerprint unica.

Cita questo